GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $13,000 | -99.8% | 60 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $6,183,000 | +16.7% | 53,573 | -1.6% | 0.06% | -5.8% |
| Q3 2020 | $5,298,000 | -22.0% | 54,418 | -1.7% | 0.07% | -27.4% |
| Q2 2020 | $6,791,000 | +37.1% | 55,336 | -2.2% | 0.10% | +9.2% |
| Q1 2020 | $4,955,000 | -15.7% | 56,583 | +0.7% | 0.09% | +11.5% |
| Q4 2019 | $5,876,000 | +35.3% | 56,193 | +48.9% | 0.08% | +27.9% |
| Q3 2019 | $4,342,000 | -4.1% | 37,745 | +43.7% | 0.06% | -11.6% |
| Q2 2019 | $4,529,000 | +1.2% | 26,271 | -1.0% | 0.07% | -4.2% |
| Q1 2019 | $4,474,000 | +50.1% | 26,540 | -13.3% | 0.07% | +22.0% |
| Q4 2018 | $2,980,000 | – | 30,596 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
| Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
| Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
| Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
| Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
| GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
| Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
| Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
| Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |